Solid Synthetic Organic Polymer Patents (Class 514/772.3)
-
Patent number: 9017644Abstract: The present invention relates to dendrimer compositions configured for treating inflammatory disorders and autoimmune disorders, and related methods of synthesis. Specifically, the present invention relates to methods for treating rheumatoid arthritis with PAMAM dendrimers having functional ligands configured for treating rheumatoid arthritis (e.g., therapeutic agents, pro-drugs, targeting agents, trigger agents, imaging agents) (e.g., methotrexate).Type: GrantFiled: November 9, 2009Date of Patent: April 28, 2015Assignee: The Regents of the University of MichiganInventors: James R. Baker, Jr., Larry A. Sternson, David Repp, Deborah Ladenheim
-
Patent number: 9017702Abstract: A formulation includes one or more active ingredients of poor water solubility for medical or non-medical use in the rearing of animals. The formulation is suitable for administration to the animals via their drinking water. It exhibits superior stability. The formulation comprises an active ingredient, a thickener combination and water, wherein the thickener combination comprises at least one thickener selected from the following groups A, B, C and D: (A) cellulose derivatives, such as methyl cellulose, sodium carboxy methyl cellulose, (B) non-cellulosic polysaccharide thickeners such as xanthan gums, Arabic gum, (C) cross-linked polyacrylic acid polymers, (D) hydrocolloidal hydrated silicates.Type: GrantFiled: July 6, 2011Date of Patent: April 28, 2015Assignee: KRKA, D.D., Novo MestoInventors: Denise Leskovar, Franc Vrecer, Andrejka Kramar, Ivanka Kolenc, Ivan Gobec, Helena Princ
-
Publication number: 20150110772Abstract: The invention provides hydrogel, wherein the hydrogel has a supramolecular cross-linked network obtainable or obtained from the complexation of an aqueous composition including a host, such as cucurbituril, and one or more polymers having suitable guest functionality. One or more polymers in the aqueous composition may have a molecular weight of 50 kDa or more, such as 200 kDa or more. The hydrogel may hold a component, such as a therapeutic compound or a biological molecule. The hydrogels are suitable for use in medicine.Type: ApplicationFiled: February 20, 2013Publication date: April 23, 2015Inventors: Oren Scherman, Eric Appel, Xian Jun Loh, Frank Biedermann, Matthew Rowland
-
Publication number: 20150112244Abstract: Otologic materials and methods are provided. For example, a cell-adhesive, biodegradable hydrogel scaffold loaded with time-released drugs for repairing chronic tympanic membrane perforations is disclosed, methods of making same and administering same are provided. This hydrogel may promote vascular in-growth and epithelial cell growth of the tympanic membrane with the purpose of closing the perforation and providing a barrier between the external and middle ear. The hydrogel is initially a liquid polymer that only gels upon exposure to specific conditions, such as exposure to light. This scaffold may simultaneously induce repair of the tympanic membrane while preventing or alleviating middle ear infection, thus filling a void in current tympanic membrane perforation therapies.Type: ApplicationFiled: December 28, 2014Publication date: April 23, 2015Applicant: The Administrators of the Tulane Educational FundInventors: Elaine Horn-Ranney, Parastoo Khoshakhlagh, Michael Moore, Jesse Ranney
-
Publication number: 20150111812Abstract: Hydrogels and hybrid hydrogels, methods of making the hydrogels/hybrid hydrogels, and methods of using the hydrogels/hybrid hydrogels. The hydrogels have polysaccharide moieties (e.g., chitosan or hyaluronic acid moieties). The hybrid hydrogels have polysaccharide moieties (e.g., chitosan or hyaluronic acid moieties) and poly(ester amide) moieties. The poly(ester amide) moieties can have one or more arginine moieties. The hydrogels/hybrid hydrogels can be used, for example, in consumer products and as cargo carrier materials (e.g., as therapeutic agent carriers).Type: ApplicationFiled: May 31, 2013Publication date: April 23, 2015Inventors: Chih-Chang Chu, DeQun Wu, Mingyu He
-
Patent number: 9012677Abstract: The present invention relates to the discovery of new class of hydrolysable amino acid derivatives and absorbable polyester amides, polyamides, polyepoxides, polyureas and polyurethanes prepared therefrom. The resultant absorbable polymers are useful for drug delivery, tissue engineering, tissue adhesives, adhesion prevention, bone wax formulations, medical device coatings, stents, stent coatings, highly porous foams, reticulated foams, wound care, cardiovascular applications, orthopedic devices, surface modifying agents and other implantable medical devices. In addition, these absorbable polymers should have a controlled degradation profile.Type: GrantFiled: November 14, 2014Date of Patent: April 21, 2015Assignee: Bezwada Biomedical, LLCInventor: Rao S Bezwada
-
Patent number: 9012424Abstract: The present invention relates to a polymer according to Formulas (1) or (2): The present invention further relates to nanogels and nanoparticles made of a polymer according to general Formulas (1) and (2). The nanogels may comprise a biologically active component such as siRNA, miRNA, DNA, an (oligo)peptide or a proteins.Type: GrantFiled: May 25, 2012Date of Patent: April 21, 2015Assignee: 20MED Therapeutics B.V.Inventors: Johannes Franciscus Joseph Engbersen, Arkadi Vladimirovich Zinchenko
-
Publication number: 20150100086Abstract: A composition includes polydioxanone and/or a copolymer thereof and at least one carboxylic salt. A molding includes the composition. A thread includes the composition. A medical kit includes the composition and a medical product includes the composition.Type: ApplicationFiled: March 28, 2013Publication date: April 9, 2015Applicant: ITV Denkendorf Produktservice GmbHInventors: Sven Oberhoffner, Erhard Müller
-
Patent number: 9000052Abstract: A perfuming composition capable of prolonging the release of a perfuming component into the surrounding environment when applied on a surface. This composition utilizes hydrophobic block copolymers in the presence of high amounts of ethanol. The invention also relates to consumer articles containing such compositions. It finally provides methods for the perfuming of a surface and a method for increasing the long-lastingness of a perfuming component using these compositions.Type: GrantFiled: October 19, 2009Date of Patent: April 7, 2015Assignee: Firmenich SAInventors: Damien Berthier, Sébastien Lecommandoux, Isabelle Schmidt, Christophe Schatz
-
Patent number: 9000053Abstract: A method of producing an emulsion includes preparing a droplet solution comprising first and second molecular species, the droplet solution being in a fluid phase, wherein the first molecular species is soluble in the second molecular species; forming a plurality of droplets from the droplet solution in a bulk fluid to create a first emulsion, the plurality of droplets having a first ensemble average radius in the bulk fluid, wherein the first molecular species of the droplet solution is at least partially soluble in the bulk fluid and the droplet solution is at least partially immiscible in the bulk fluid; and allowing molecules of the first molecular species to migrate from the plurality of fluid droplets to the bulk fluid due to a higher concentration of the first molecular species in the droplet solution than the bulk fluid to result in the plurality of droplets having a second ensemble average radius that is smaller than the first ensemble average radius.Type: GrantFiled: June 17, 2009Date of Patent: April 7, 2015Assignee: The Regents of the University of CaliforniaInventors: Thomas G. Mason, Michael M. Fryd
-
Patent number: 8999378Abstract: The present invention provides porous electroactive hydrogels, the deformation angle of which is controlled by electroactuation, and methods for preparing and using such hydrogels.Type: GrantFiled: September 24, 2009Date of Patent: April 7, 2015Assignee: President and Fellows of Harvard CollegeInventors: Kevin Kit Parker, Megan O'Grady
-
Patent number: 8992991Abstract: Degradable polymers were synthesized that self-assemble with DNA to form particles that are effective for gene delivery. Small changes to polymer synthesis conditions, particle formulation conditions, and polymer structure provides significant changes to efficacy in a cell-type dependent manner. Polymers presented here are more effective than commercially available materials, such as LIPOFECTAMINE 2000™, FUGENE®, or polyethylenimine (PEI), for gene delivery to cancerous fibroblasts or human primary fibroblasts. The presently disclosed materials may be useful for cancer therapeutics and regenerative medicine.Type: GrantFiled: May 17, 2010Date of Patent: March 31, 2015Assignee: The Johns Hopkins UniversityInventors: Jordan J. Green, Joel C. Sunshine, Nupura S. Bhise, Ron B. Shmueli, Stephany Y. Tzeng
-
Patent number: 8993831Abstract: Medical implants and methods useful in treating postpartum hemorrhage are disclosed. The implants, in some embodiments, comprise polyurethane foams having advantageous mechanical and other properties selected to promote hemostasis when brought in contact with an inner wall of a uterus. Methods of making and deploying such implants are also disclosed.Type: GrantFiled: June 28, 2012Date of Patent: March 31, 2015Assignee: Arsenal Medical, Inc.Inventors: Upma Sharma, Irina Gitlin, Parisa Zamiri, Toby Freyman, Rany Busold, Lee Core, Janet Chie Komatsu, Jennifer Mortensen
-
Patent number: 8987339Abstract: Provided herein are pre-formulations forming a biocompatible hydrogel polymer comprising at least one nucleophilic compound or monomer unit, at least one electrophilic compound or monomer unit, and optionally a therapeutic agent and/or viscosity enhancer. In some embodiments, the biocompatible hydrogel polymer covers a wound in a mammal and adheres to the surrounding skin tissue. In other embodiments, the hydrogel polymer is delivered into a joint space to treat joint disease or navicular disease.Type: GrantFiled: March 14, 2014Date of Patent: March 24, 2015Assignee: Medicus Biosciences LLCInventors: Syed H. Askari, Yeon S. Choi
-
Publication number: 20150080301Abstract: Disclosed are novel bioabsorbable and biodegradable monomer compounds, bioabsorbable and biodegradable polymers therefrom, and methods of making such monomers and polymers, which are useful in pharmaceutical delivery systems, tissue engineering applications, tissue adhesives products, implantable medical devices, foams and reticulated foams for wound healing and drug delivery, bone hemostats and bone void fillers, adhesion prevention barriers, meshes, filters, stents, medical device coatings, pharmaceutical drug formulations, consumer product and cosmetic and pharmaceutical packaging, apparel, infusion devices, blood collection tubes and devices, other medical tubes, skin care products, and transdermal drug delivery materials.Type: ApplicationFiled: November 20, 2014Publication date: March 19, 2015Inventor: Rao S. Bezwada
-
Patent number: 8980278Abstract: The present invention is directed to a bio-functionalized stimulus-responsive dissolvable PEG-hydrogel. This inventive stimulus-responsive dissolvable PEG-hydrogel comprises a matrix of PEG-polymers, which are modified to contain at least one multifunctional fusion protein, the multifunctional fusion protein preferably comprising as components a substrate binding peptide (SBP), preferably a repetitive RGD-binding peptide and/or a ZZ-binding domain, preferably a tag for purification, and at least one N- and/or C-terminal linker. The present invention is furthermore directed to the use of such inventive stimulus-responsive dissolvable PEG-hydrogels in the treatment of lesions, in surgical dressings, for wound treating, for soft and hard tissue regeneration, for the treatment of wounds in the oral cavity, in the field of ophthalmology, in the field of periodontal defects, etc. The invention also describes a method of treatment for such diseases.Type: GrantFiled: November 18, 2011Date of Patent: March 17, 2015Assignees: Universitaetsklinikum Freiburg, Albert-Ludwigs-Universitaet FreigburgInventors: Thorsten Steinberg, Wilfried Weber, Raphael Guebeli, Pascal Tomakidi, Dougal Laird
-
Patent number: 8980957Abstract: The subject invention relates to a method of preparing a biocompatible polymer comprising epsilon-linked L-lysine having free alpha-amino and carboxy functions. The invention further encompasses the resulting biocompatible polymer and articles made from the polymer, in particular contact and intraocular lenses.Type: GrantFiled: January 11, 2011Date of Patent: March 17, 2015Assignee: CIS Pharma AGInventors: Rolf Schäfer, Hans Hitz
-
Publication number: 20150071981Abstract: The present invention provides compositions for extended release of an active ingredient, comprising a lipid-saturated matrix formed from a biodegradable polymer. The present invention also provides methods of producing the matrix compositions and methods for using the matrix compositions to provide controlled release of an active ingredient in the body of a subject in need thereof.Type: ApplicationFiled: October 26, 2014Publication date: March 12, 2015Inventor: Noam EMANUEL
-
Publication number: 20150065442Abstract: Reductively degradable micelles comprising poly(-?amino ester)s-g-poly(ethylene glycol) amphiphilic copolymers provided with aromatic phenylbutylamine side groups, suitable for sequestering therein anthrocyclines. The anthrocycline-loaded reductively degradable micelles are useful for therapeutic treatment of cancers.Type: ApplicationFiled: January 15, 2013Publication date: March 5, 2015Inventor: Malcolm M.Q. Xing
-
Patent number: 8968782Abstract: The present invention relates to relates to combination degradable and non-degradable matrices and related methods. In an embodiment, the invention includes an active agent delivery matrix including a degradable polymer network, a non-degradable polymer network, the non-degradable polymer network interspersed within the degradable polymer network, and an active agent. In an embodiment, the invention includes an active agent elution control matrix including a degradable polymer; and a non-degradable polymer interspersed with the degradable polymer. In an embodiment, the invention includes a method of making an active agent delivery matrix including mixing a degradable polymer with a first solvent to form a degradable polymer solution; mixing a non-degradable polymer with a second solvent to form a non-degradable polymer solution; and simultaneously depositing the degradable polymer solution and the non-degradable polymer solution onto a substrate.Type: GrantFiled: June 28, 2007Date of Patent: March 3, 2015Assignee: SurModics, Inc.Inventors: Ralph A. Chappa, Robert W. Hergenrother, Paula Bushendorf, Joram Slager
-
Patent number: 8968783Abstract: The present disclosure relates to a hydrogel composition and methods of using the same. The hydrogel composition may include precursors that react with each other upon contact as well as precursors that react upon contact with an initiator. In embodiments, the resulting hydrogels may have varying levels of crosslinking with both denser and less dense regions.Type: GrantFiled: May 24, 2011Date of Patent: March 3, 2015Assignee: Covidien LPInventors: Steven Bennett, Nathaniel Mast, Kevin Lavigne, Walter Skalla
-
Publication number: 20150057368Abstract: Methods to produce substantially closed cell foams with densities less than 0.75 g/cm3, and more preferably less than 0.5 g/cm3, without substantial loss of the polymer's weight average molecular weight, have been developed. The closed cells foams have an open cell content of generally less than 50%, and more preferably an open cell content of less than 20%, and the cells have a maximum diameter of less than 5 mm. The foam may include poly-4-hydroxybutyrate or a copolymer thereof. Preferably, the foam is derived by heating a foam polymer formula to a temperature above the melt temperature of the polymer to form a melt polymer system, adding a blowing agent to produce a foamable melt, extruding the foamable melt through a die to a lower pressure to cause foaming, cooling of the foam, and solidification of the foam. These foam structures can be used for fabrication of medical products.Type: ApplicationFiled: August 20, 2014Publication date: February 26, 2015Inventors: Dennis Connelly, Fabio Felix, David P. Martin, Jon Montcrieff, Said Rizk, Simon F. Williams
-
Publication number: 20150056131Abstract: Methods to produce thermoforms from P4HB homopolymer and blends thereof have been developed. These thermoforms are produced from films and sheets including P4HB, wherein the intrinsic viscosity of the P4HB is less than 3.5 dl/g, but greater than 0.35 dl/g, and the thermoforms are produced at a temperature equal to or greater than the softening point of P4HB, and more preferably at a temperature higher than the melting point of P4HB. A preferred embodiment includes a P4HB thermoform wherein a film or sheet including a P4HB polymer is thermoformed at a temperature between its melting point and 150° C. In a particularly preferred embodiment the thermoform is a laminate made from a P4HB film and a P4HB mesh.Type: ApplicationFiled: August 20, 2014Publication date: February 26, 2015Inventors: Matthew Bernasconi, Dennis Connelly, Said Rizk, David P. Martin, Simon F. Williams
-
Patent number: 8956638Abstract: A method is provided for the preparation of a poly(amic acid) in which ring opening polymerization is employed to react the monomers ethylenediaminetetraacetic dianhydride and paraphenylenediamine in an aprotic solvent. The resulting poly(amic acid) composition is suitable as a biocompatible material, such as a biomedical implant, implant coating material, tissue scaffold material, controlled release drug delivery vehicle, and cellular growth substrate.Type: GrantFiled: April 8, 2011Date of Patent: February 17, 2015Assignee: Axcelon Biopolymers CorporationInventors: Wankei Wan, Donna Padavan
-
Bioactive polymeric liquid formulations of absorbable, segmented aliphatic polyurethane compositions
Patent number: 8952075Abstract: Bioactive liquid formulations are formed of combinations of absorbable, segmented aliphatic polyurethane compositions and liquid polyether for use as vehicles for the controlled release of at least one active agent for the conventional and unconventional treatment of different forms of cancer and the management of at least one type of bacterial, fungal, and viral infection.Type: GrantFiled: May 22, 2009Date of Patent: February 10, 2015Assignee: Poly-Med, Inc.Inventor: Shalaby W. Shalaby -
Publication number: 20150037306Abstract: The present invention relates to a method for controlling insects comprising the steps of preparing a tankmix by mixing a larvicide and a liquid adjuvant, wherein the adjuvant is essentially free of the larvicide and contains at least 1 wt % polyorganosiloxane, and at least 20 wt % synthetic organic solvent; and applying the tankmix on a water surface. The invention further relates to a liquid adjuvant for preparing a larvicidal tankmix, wherein the adjuvant is essentially free of a larvicide and contains at least 1 wt % polyorganosiloxane, and at least 20 wt % synthetic organic solvent. Finally, it relates to a method for preparing said adjuvant, comprising mixing the polyorganosiloxan and the synthetic organic solvent.Type: ApplicationFiled: January 21, 2013Publication date: February 5, 2015Applicant: BASF SEInventors: Claude Taranta, Helmut Mueller, Susanne Stutz, Egon Weinmueller, James W. Austin
-
Publication number: 20150030649Abstract: The present invention provides a cosmetic composition that is stable, not sticky when used, has excellent moisture and smoothness, and maintains the effects for a long time without deterioration due to washing and/or sweating. Specifically, the present invention provides a cosmetic composition that comprises: (i) a polyalkylene oxide-modified product obtained by reacting a polyalkylene oxide compound, a diol compound, and a diisocyanate compound; and (ii) water or a lower alcohol aqueous solution, wherein the cosmetic composition comprises 0.3 mass % or more polyalkylene oxide-modified product.Type: ApplicationFiled: March 13, 2013Publication date: January 29, 2015Applicant: Sumitomo Seika Chemicals Co., Ltd.Inventors: Hitoshi Ozawa, Tsuyoshi Masuda, Yusuke Nishikawa
-
Patent number: 8940799Abstract: Drug loading of polymeric materials can be adjusted by selection of materials and/or adjusting processing steps in formation of an implantable drug-loaded device.Type: GrantFiled: March 25, 2010Date of Patent: January 27, 2015Assignee: Medtronic Xomed, Inc.Inventors: William Jeffrey Bertrand, Patrick Marek, Drew Amery
-
Publication number: 20150025144Abstract: The invention proposes a container further extending the shelf life of foods, particularly berries, by including an active agent having antifungal capability into the container surface so that when the fruit is packaged inside the container it is permanently exerted an antifungal effect over the surface, which is the place on the longer determinants occurs, but also contributing to preserve the general environment. Also it proposes a preparation process and its use.Type: ApplicationFiled: October 1, 2014Publication date: January 22, 2015Inventors: Maria Paula Junqueira Conceicao Gonsalves, Andrea Marcarena Tapia Ulloa
-
Patent number: 8936797Abstract: The present invention relates to polymer ic thickener compositions comprising at least one water-swellable crosslinked copolymer, a process for preparing such compositions and their use as a thickener, e.g., in cosmetic, dermatologic, pharmaceutical or veterinary formulations. The water-swellable crosslinked copolymer according to the present invention is prepared from a mixture comprising (a) acrylamide, (b) an acrylamidoalkylsulfonic acid and/or a salt thereof and (c) an amine-based polyfunctional crosslinking agent comprising at least three allylic functions.Type: GrantFiled: December 21, 2007Date of Patent: January 20, 2015Assignee: S.P.C.M. S.A.Inventor: Frédéric Blondel
-
Patent number: 8933133Abstract: Animal feed compositions which include a polyol are described. Processes for producing an animal feed composition with a polyol are disclosed. Methods of feeding an animal the polyol are also disclosed.Type: GrantFiled: December 14, 2007Date of Patent: January 13, 2015Assignee: ADM Alliance Nutrition, Inc.Inventors: Stephanie S. Block, Perry H. Doane
-
Patent number: 8927529Abstract: A method for the treatment of back pain by injection of an injectable flowable composition in the epidural space, wherein the composition is composed of microparticles of dexamethasone acetate and a polymer, are disclosed.Type: GrantFiled: January 29, 2013Date of Patent: January 6, 2015Assignee: SpineTheraInventor: Jeff Missling
-
Publication number: 20150004212Abstract: The present invention is directed to linear, biodegradable polyesteramide (PEA) polymers synthesized with repeating units derived from aminophenol esters and diacids. These PEAs have a monomer repeat represented by as well as a variety of uses to coat, form or comprise medical devices, combination medical devices and pharmaceutical compositions, including sustained release formulations.Type: ApplicationFiled: September 19, 2014Publication date: January 1, 2015Inventors: Arthur Schwartz, Satish Pulapura, Sarita Nethula, Archana Rajaram, Arikha Moses
-
Publication number: 20150004197Abstract: The present invention provides a polymer fibre comprising a thermoplastic polymer comprising the following building blocks A and B: —O—(CH2—CH2—O)n— (A) —O—[CH2]y—O— (B), wherein n is an integer of 10-400, and y is an integer in the range of 2 to 16, wherein A is present in an amount of 15-30 mole %, B is present in an amount of 20-40 mole % and wherein building blocks A and B are linked by the following linking group C: —[(C?O)—NH—CH2—CH2—CH2—CH2—CH2—CH2—NH—(C?O)]— (C) wherein C is present in an amount of 45-55 mole %. The present invention further relates to a method for preparing a polymer fibre, absorbent articles comprising a polymer fibre and the use of a fibre in a product for treating wounds and/or burns.Type: ApplicationFiled: September 20, 2012Publication date: January 1, 2015Applicant: MOLNLYCKE HEALTH CARE ABInventors: Sebastian Doerr, Dennis Hansson
-
Publication number: 20150004257Abstract: A polymeric composition capable of releasing nitric oxide and modulating biological responses comprises a biocompatible polymer and S-nitrosated thiol bonded to the biocompatible polymer. The polymeric composition can have a thiol conversion of at least 40%. The polymeric composition can also have a nitric oxide recovery of at least 40% when under thermal decomposition conditions.Type: ApplicationFiled: February 23, 2012Publication date: January 1, 2015Applicant: Colorado State University Research FoundationInventors: Melissa M. Reynolds, Vinod B. Damodaran
-
Patent number: 8921429Abstract: The present invention is directed to a crosslinked or non-crosslinked polymer particle, wherein the crosslinked polymer particle comprises a copolymer of poly(alklyene glycol-graft-lactate) that is crosslinked by at least one hydrolysable monmer. Another embodiment of the present invention is a polymer particle comprising a crosslinked polymer particle that is a product of starting materials comprising (a) a hydrophilic monomer, (b) a hydrophobic monomer, and (c) a hydrolysable crosslinking agent. Another embodiment of the present invention is a polymer particle comprising, a crosslinked copolymer comprises structures represented by Formulas (I), (II), and (III), where Formulas (I), (II) and (III) are defined in the specification. Yet other embodiments of the present invention include a method of preparing a methacrylate terminated macromonomer, a method of preparing a crosslinking agent, and a method of preparing a therapeutic agent loaded nanosphere by dispersion polymerization.Type: GrantFiled: November 23, 2010Date of Patent: December 30, 2014Assignee: Howard UniversityInventors: Emmanuel Akala, Simeon Adesina
-
Publication number: 20140378553Abstract: A method for producing an organopolysiloxane emulsion composition, which enables the organopolysiloxane to be formed with a high viscosity in a short period of time, and suppresses the amount of octamethylcyclotetrasiloxane (D4) to not more than 3,000 ppm. Specifically, a method for producing an organopolysiloxane emulsion which includes emulsifying a mixture containing an organopolysiloxane represented by formula: HO(R12SiO)nH and having a D4 content of not more than 1,000 ppm, a nonionic surfactant, an anionic surfactant, and water, and subjecting the obtained emulsion composition to emulsion polymerization, thus preparing the emulsion composition.Type: ApplicationFiled: January 24, 2013Publication date: December 25, 2014Applicant: Shin-Etsu Chemical Co., Ltd.Inventor: Yuji Ando
-
Publication number: 20140370064Abstract: A film-forming composition comprises a solvent and unimolecular nanoparticles of a self-crosslinkable nanogel star polymer. The nanogel star polymer comprises i) a crosslinked polymer core (nanogel core) and ii) 6 or more independent polymer arms covalently linked to the core by respective first end groups. A plurality of the arms comprise reactive groups for effecting crosslinking of the nanoparticles. An essentially solvent-free film layer comprising the nanoparticles self-crosslinks, optionally assisted by subjecting the film layer to a thermal treatment and/or a photochemical treatment. A surface treated article comprising the crosslinked film layer can effectively inhibit growth of and/or kill Gram-negative microbes, Gram-positive microbes, fungi, and/or yeasts.Type: ApplicationFiled: June 16, 2013Publication date: December 18, 2014Inventors: Victor Y. Lee, Robert D. Miller, Joseph Sly
-
Patent number: 8912247Abstract: Improved methods for preparing polyethylene glycol fumarate) are disclosed. Methods for chemically crosslinking or photocross-linking hydrophilic polyethylene glycol fumarate) with hydrophobic polymers such as poly(propylene fumarate) (PPF) and poly(caprolactone fumarate) (PCLF) to form various hydrogels (FIG. 1) with controllable hydrophilicity are also disclosed. The hydrogels are useful in the fabrication of injectable and in-situ hardening scaffolds for application in skeletal reconstruction. An injectable material including the hydrogels may be useful in controlled drug release.Type: GrantFiled: April 28, 2006Date of Patent: December 16, 2014Assignee: Mayo Foundation for Medical Education and ResearchInventors: Shanfeng Wang, Lichun Lu, Michael J. Yaszemski
-
Patent number: 8906403Abstract: A method for preparing a biomaterial containing at least one bioactive molecule from a base biomaterial, comprising the following successive operations carried out on the base biomaterial: a) application of a solid mixture of: cyclodextrin(s) and/or cyclodextrin derivative(s) and/or cyclodextrin inclusion complex(es) and/or cyclodextrin derivative inclusion complex(es), at least one poly(carboxylic) acid, and optionally a catalyst; b) heating at a temperature between 100° C. and 200° C. for a period of 1 to 60 minutes; c) washing with water; d) drying, wherein at least one bioactive agent is incorporated in the biomaterial by impregnation of the biomaterial after the drying step in a concentrated solution of the bioactive agent.Type: GrantFiled: November 15, 2005Date of Patent: December 9, 2014Assignees: Universite des Sciences et Technologies de Lille SAIC, Universite de Droit et SanteInventors: Bernard Martel, Nicolas Blanchemain, François Boschin, Stephan Haulon, Elisabeth Delcourt Debruyne, Michel Morcellet, Hartmut Friederich Hildebrand
-
Publication number: 20140356303Abstract: Described herein is a silicone replacement for use in a personal care formulation comprising a mixture of at least one polymeric ester and at least one non-polymeric ester. The polymeric ester is an esterification reaction product of (i) at least one first dicarboxylic acid, (ii) at least one first monofunctional alcohol or monofunctional carboxylic acid and (iii) glycerin or derivatives thereof. The non-polymeric ester is an esterification reaction product of (i) at least one second dicarboxylic acid and (ii) at least one second monofunctional alcohol, wherein the replacement is substantially free of silicone. As described is a personal care formulation that is substantially free of silicone, wherein the formulation comprises a silicone replacement consisting substantially of a mixture of at least one polymeric ester as described above, and a non-polymeric ester as described above. Related methods are also described.Type: ApplicationFiled: May 13, 2014Publication date: December 4, 2014Applicant: INOLEX INVESTMENT CORPORATIONInventors: BURGO Rocco, WINN Daniel, BURCH Kimberly
-
Publication number: 20140357730Abstract: Included are polymer compositions such as polyurethaneureas, polyamides and polyesters. The compositions may be in a variety of forms such as dispersions, powders, fibers, and beads. The compositions are useful in the preparation of many products including health and beauty products such as cosmetics, paint, household products such as fabric care compositions, apparel/footwear and textiles/furnishings.Type: ApplicationFiled: August 20, 2014Publication date: December 4, 2014Applicant: INVISTA North America S.à r.l.Inventors: Hong LIU, Charles Frank Iavarone, James Michael Lambert, Sonia Menot, Federica Maria Roberta Stoppa
-
Publication number: 20140357729Abstract: It is an object to provide a topical composition that is excellent in texture and feeling upon use. The present invention is a topical composition without water, satisfying the following: (A) the composition includes a silicone base in a proportion of 80% by weight or more; (B) the silicone base includes (b1) a silicone elastomer, (b2) a cyclic volatile methylsiloxane having 3 to 6 silicon atoms, and (b3) a linear dimethylpolysiloxane and/or linear methylphenylpolysiloxane; (C) the composition includes therein an active ingredient present in a dispersed or dissolved type; and (D) the composition does not contain any non-silicone thickener.Type: ApplicationFiled: December 20, 2012Publication date: December 4, 2014Inventors: Eijiro Horisawa, Mikito Ihara
-
Patent number: 8901341Abstract: The present invention relates to the discovery of new class of hydrolysable amino acid derivatives and absorbable polyester amides, polyamides, polyepoxides, polyureas and polyurethanes prepared therefrom. The resultant absorbable polymers are useful for drug delivery, tissue engineering, tissue adhesives, adhesion prevention, bone wax formulations, medical device coatings, stents, stent coatings, highly porous foams, reticulated foams, wound care, cardiovascular applications, orthopedic devices, surface modifying agents and other implantable medical devices. In addition, these absorbable polymers should have a controlled degradation profile.Type: GrantFiled: May 3, 2013Date of Patent: December 2, 2014Assignee: Bezwada Biomedical, LLCInventor: Rao S. Bezwada
-
Patent number: 8895630Abstract: New associative thickeners of the HEUR type (Hydrophobically modified Ethylene oxide URethane) whose hydrophobic monomer is based on alkyl cyclohexylols. These are new polyurethanes that allow a broad thickening of a medium shear gradient aqueous formulation while limiting the increase in the low shear gradient viscosity. The invention also concerns the compositions containing them and their uses in different formulations such as aqueous paints.Type: GrantFiled: June 13, 2012Date of Patent: November 25, 2014Assignee: CoatexInventors: Jean-Marc Suau, Denis Ruhlmann
-
Publication number: 20140335031Abstract: A liquid composition including between 1 and 15 parts by weight of PEBA to 100 parts by weight of solvent, wherein: said solvent includes between 1 and 49% by volume of alcohol low in C1 to C4 and between 51 and 99% by volume of a cosolvent miscible with alcohol, in the total volume of solvent. Further, use of such a composition for producing water-resistant objects, such as coatings, films, varnishes, paints, in particular anti-graffiti coatings, seals, in particular sealing joints, personal protective equipment, gloves, flexible masks, condoms, and protective equipment for electronic or computer hardware.Type: ApplicationFiled: January 4, 2013Publication date: November 13, 2014Inventors: Frédéric Malet, Marie-Ange Michel
-
Publication number: 20140336277Abstract: Radiopaque, iodinated, absorbable polyesters, polyester urethanes, and polyether-ester-urethanes with and without inorganic iodide micro-/nanoparticles dispersed or solubilized therein, and composite inorganic iodide micro-/nanoparticles in an absorbable polyester, polyester-urethane, polyester-ester, or polyether-ester urethane matrix are employed in medical devices and therapeutic compositions.Type: ApplicationFiled: July 22, 2014Publication date: November 13, 2014Applicant: POLY-MED, INC.Inventors: Shalaby W. Shalaby, Kenneth David Gray
-
Patent number: 8883221Abstract: Micronutrient combination product, wherein the micronutrient combination product comprises zeaxanthin, lutein, zinc and copper.Type: GrantFiled: December 17, 2004Date of Patent: November 11, 2014Assignee: Bausch & Lomb IncorporatedInventors: Guenter Bellmann, Gudrun Claus-Herz
-
Patent number: 8883861Abstract: Disclosed are biocompatible, bioresorbable polymers comprising a plurality of monomeric repeating units containing an imine group, wherein the inclusion of said imine group is effective to lower the melt viscosity, the solution viscosity, or both, compared to the same polymer without an imine group.Type: GrantFiled: November 1, 2011Date of Patent: November 11, 2014Assignee: Rutgers, The State University of New JerseyInventors: Joachim B. Kohn, Durgadas Bolikal
-
Publication number: 20140328774Abstract: An oil-in-water emulsion skin care composition comprising from about 3% to about 25%, by weight of the composition, of a hydrocarbon oil or a mixture thereof, from about 2% to about 15%, by weight of the composition, of silicone particles or a mixture thereof, from about 0.1% to about 5%, of an emulsifier or a mixture thereof, and from about 30% to about 90%, by weight of the composition, of water. The composition provides a pleasing skin sensory without much affecting occlusivity.Type: ApplicationFiled: May 3, 2013Publication date: November 6, 2014Applicant: The Procter & Gamble CompanyInventors: Suryamani ROUT, Naohisa YOSHIMI